Anas younes biography of michael
Dr. Anas Younes, MD | New York, NY | Oncologist | US News Doctors
- Anas Younes, Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D, leads the new Haematology R&D unit.
The power of combinations in blood cancers - Drug Target Review
Dr. Anas Younes, MD – New York, NY | Oncology - Doximity
- Anas Younes, Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D, leads the new Haematology R&D unit.
Anas YOUNES | Memorial Sloan Kettering Cancer Center, New ...
- Professor Anas Younes is a Professor of Medicine at the Weill-Cornell Medical College, and the Special Advisor to the Chairman of Medicine for Research and the Steven A. Greenberg Chair in Lymphoma Research at the Memorial Sloan Kettering Cancer Center New York, US.
Anas Younes MD - VJHemOnc
Anas Younes on LinkedIn: It has been a year since I joined ...
- Experience: AstraZeneca · Education: Memorial sloan kttering cancer center · Location: New York · +.
Anas Younes: Transforming outcomes for people living with Blood Cancer
Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at AstraZeneca, shared a post on LinkedIn:
“As we wrap up the year, I want to express my thanks to our Hematology R&D team at AstraZeneca for their dedication and hard work in aiming to transform outcomes for people living with Blood Cancer.
I’m incredibly proud of the strides we’ve made this year.
We welcomed over 70 talented individuals to our world-class team, growing our community to 300+ experts across 8 countries.
Key appointments include:
- Lisa Drew, Head of Small Molecule Discovery, Hematology R&D.
- Bruno Medeiros, Executive Medical Director – Global Head of Leukemia Strategy.
- Yasuhiro Oki, Global Clinical Head of Lymphoma.
- Margie Li, Global Clinical Head and Product Leader, Cell Therapy.
We’ve also established a dedicated pediatric working team to address the unique hematology
Anas Younes - AstraZeneca - LinkedIn
Anas Younes - AstraZeneca
| Corresponding author: Anas Younes, MD, Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe. | |
| Professor Anas Younes is a Professor of Medicine at the Weill-Cornell Medical College, and the Special Advisor to the Chairman of Medicine for Research and the Steven A. Greenberg Chair in Lymphoma Research at the Memorial Sloan Kettering Cancer Center New York, US. | |
| In our cover story, we explore why funding from organizations like LRF has become crucial to improving researchers' ability to obtain federal. |